Huntington SF, Manzoor BS, Puckett JT, Kamal-Bahl S, et al. Real-world adherence and discontinuation among Medicare beneficiaries initiating venetoclax vs. BTKis in relapsed/refractory chronic lymphocytic leukemia. Leuk Lymphoma 2023 Sep 21:1-8. doi: 10.1080/10428194.2023.2255326.
PMID: 37732602